Detailed price information for Pasithea Therapeutics Corp (KTTA-Q) from The Globe and Mail including charting and trades.

BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in the EU and ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s CAPItello-292 study aims to evaluate the ...

Lantern Pharma advances pediatric CNS cancer treatment with FDA guidance on LP-184 trial, targeting rare tumors and enhancing ...

Aims: Preclinical studies indicate that magnetic stimulation may be an efficacious treatment for intractable hiccups in post-stroke patients. This study aimed to investigate repetitive peripheral ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. To address this delay, the ...

Trials are being run in parallel, but the baseline is currently run alone, would be nice to start trials in parallel with the baseline since the trials are independent of the baseline (I think).

Due to the changing regulatory landscape, developing and distinguishing new investigational products from approved treatment options is challenging. That is why advances in treatments, especially in ...

Industrial digital input chips provide serialized data by default. However, in systems that require real time, low latency, or higher speed, it may be preferable to provide level-translated, real-time ...

Join a candid and informative discussion between two precision medicine experts who led one of the world’s largest precision medicine studies to date. They will share lessons learned and concrete ...

Abstract: This paper investigates the codebook design for the novel parallel dynamic subarrays for millimeter-wave (mmWave) massive MIMO systems. To generate high-resolution patterns, we design a ...